ST3932

ST3932 Suppliers list
Company Name: Twochem Co.Ltd.  
Tel: 021-58111628 15800915896
Email: sales@twochem.com
Company Name: Tianjin Kaifu Pharmaceutical Technology Co., Ltd.  
Tel: 18081075745
Email: chemflowtech@sina.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: cjbscvictory  
Tel: 13348960310 13348960310
Email: 3003867561@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com

ST3932 manufacturers

  • ST3932
  • ST3932 pictures
  • $1670.00
  • 2026-04-21
  • CAS:1246018-21-2
  • Purity:
  • Supply Ability: 10g
  • ST3932
  • ST3932 pictures
  • $1670.00
  • 2025-07-18
  • CAS:1246018-21-2
  • Purity:
  • Supply Ability: 10g
ST3932 Basic information
Product Name:ST3932
Synonyms:ST3932;ST-3932,ST3932;9H-Purine-2-propanol, 6-amino-α,9-dimethyl-8-(2H-1,2,3-triazol-2-yl)-;4-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-ol
CAS:1246018-21-2
MF:C12H16N8O
MW:288.32
EINECS:
Product Categories:
Mol File:1246018-21-2.mol
ST3932 Structure
ST3932 Chemical Properties
Boiling point 482.7±55.0 °C(Predicted)
density 1.62±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Soluble in DMSO
pka14.96±0.20(Predicted)
Safety Information
MSDS Information
ST3932 Usage And Synthesis
Description

ST3932 is a metabolite of ST1535, acts as an antagonist of adenosine A2A receptor, with Kis of 8 nM and 33 nM for A2A and A1 receptors, respectively.

ST3932 is a metabolite of ST1535, acts as an antagonist of adenosine A2A receptor, with Kis of 8 nM and 33 nM for A2A and A1 receptors, respectively. ST3932 inhibits agonist-induced cAMP accumulation with an IC50 value of 450 nM[1].

ST3932 (10, 20, 40 mg/kg, p.o.) antagonizes haloperidol-induced catalepsy, and increases motor activity in mice. ST3932 (20, 40 mg/kg, i.p.) significantly increases the number of contralateral turns induced by l-DOPA in rats[1].

UsesST3932 is a metabolite of ST1535, acts as an antagonist of adenosine A2A receptor, with Kis of 8 nM and 33 nM for A2A and A1 receptors, respectively.
in vivo

ST3932 (10, 20, 40 mg/kg, p.o.) antagonizes haloperidol-induced catalepsy, and increases motor activity in mice. ST3932 (20, 40 mg/kg, i.p.) significantly increases the number of contralateral turns induced by l-DOPA in rats[1].

References

[1]. ST3932, et al. Animal models of Parkinsons disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535). Eur J Pharmacol. 2015 Aug 15;761:353-61.

ST3932 Preparation Products And Raw materials
Preparation Products2-Butanone, 4-[6-amino-9-methyl-8-(2H-1,2,3-triazol-2-yl)-9H-purin-2-yl]-
Tag:ST3932(1246018-21-2) Related Product Information
CGS 21680A NECA azd4635 N6,N6-Dimethyladenosine 8-[4-[4-(4-Chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine ZM 241385